Erica Y Tong1, Cristina P Roman2, De Villiers Smit3, Harvey Newnham4, Kirsten Galbraith5, Michael J Dooley6. 1. Pharmacy Department, The Alfred, Lower Ground Floor, Commercial Road, Melbourne, Victoria 3004, Australia; General Medical Unit, The Alfred, Commercial Road, Melbourne, Victoria 3004, Australia. Electronic address: e.tong@alfred.org.au. 2. Pharmacy Department, The Alfred, Lower Ground Floor, Commercial Road, Melbourne, Victoria 3004, Australia; The Alfred Emergency and Trauma Centre, Commercial Road, Melbourne, Victoria 3004, Australia. 3. The Alfred Emergency and Trauma Centre, Commercial Road, Melbourne, Victoria 3004, Australia. 4. General Medical Unit, The Alfred, Commercial Road, Melbourne, Victoria 3004, Australia. 5. Monash University, Faculty of Pharmacy and Pharmaceutical Sciences, Melbourne, Victoria, Australia. 6. Pharmacy Department, The Alfred, Lower Ground Floor, Commercial Road, Melbourne, Victoria 3004, Australia; Monash University, Faculty of Pharmacy and Pharmaceutical Sciences, Melbourne, Victoria, Australia.
Abstract
OBJECTIVE: A partnered medication review and charting model involving a pharmacist and medical officer was implemented in the Emergency Short Stay Unit and General Medicine Unit of a major tertiary hospital. The aim of the study was to describe the safety and effectiveness of partnered medication charting in this setting. METHODS: A partnered medication review and charting model was developed. Credentialed pharmacists charted pre-admission medications and venous thromboembolism prophylaxis in collaboration with the admitting medical officer. The pharmacist subsequently had a clinical discussion with the treating nurse regarding the medication management plan for the patient. A prospective audit was undertaken of all patients from the initiation of the service. RESULTS: A total of 549 patients had medications charted by a pharmacist from the 14th of November 2012 to the 30th of April 2013. A total of 4765 medications were charted by pharmacists with 7 identified errors, corresponding to an error rate of 1.47 per 1000 medications charted. CONCLUSIONS: Partnered medication review and charting by a pharmacist in the Emergency Short Stay and General Medicine unit is achievable, safe and effective. Benefits from the model extend beyond the pharmacist charting the medications, with clinical value added to the admission process through early collaboration with the medical officer. Further research is required to provide evidence to further support this collaborative model.
OBJECTIVE: A partnered medication review and charting model involving a pharmacist and medical officer was implemented in the Emergency Short Stay Unit and General Medicine Unit of a major tertiary hospital. The aim of the study was to describe the safety and effectiveness of partnered medication charting in this setting. METHODS: A partnered medication review and charting model was developed. Credentialed pharmacists charted pre-admission medications and venous thromboembolism prophylaxis in collaboration with the admitting medical officer. The pharmacist subsequently had a clinical discussion with the treating nurse regarding the medication management plan for the patient. A prospective audit was undertaken of all patients from the initiation of the service. RESULTS: A total of 549 patients had medications charted by a pharmacist from the 14th of November 2012 to the 30th of April 2013. A total of 4765 medications were charted by pharmacists with 7 identified errors, corresponding to an error rate of 1.47 per 1000 medications charted. CONCLUSIONS: Partnered medication review and charting by a pharmacist in the Emergency Short Stay and General Medicine unit is achievable, safe and effective. Benefits from the model extend beyond the pharmacist charting the medications, with clinical value added to the admission process through early collaboration with the medical officer. Further research is required to provide evidence to further support this collaborative model.
Authors: Tim Tran; Simone E Taylor; Andrew Hardidge; Elise Mitri; Parnaz Aminian; Johnson George; Rohan A Elliott Journal: Ther Adv Drug Saf Date: 2019-07-12
Authors: Hannah Beks; Kevin Mc Namara; Elizabeth Manias; Andrew Dalton; Erica Tong; Michael Dooley Journal: BMC Health Serv Res Date: 2021-03-19 Impact factor: 2.655